All Updates

Today, the Supreme Court of the United States announced its decision on the Loper Bright Enterprises v. Raimondo case and its companion case, Relentless v. Dept. of Commerce. The majority’s opinion abolishes the rule of Chevron deference. In response to the court’s decision, the following statement was

Today, the House Appropriations Subcommittee on Labor Health and Human Services considered and approved its draft FY25 appropriations bill that includes increases for federal cancer research funding at the National Cancer Institute (NCI).

The state legislature passed its final version of the budget, which included increased funding for programs that address tobacco use.

Tomorrow, the U.S. House Committee on Ways and Means is expected to mark up the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act.

The American Cancer Society Cancer Action Network (ACS CAN) thanks Sen. Nickie Antonio for championing an effort to invest in the American Cancer Society’s Cleveland Hope Lodge, a nurturing home away from home for cancer patients and their caregivers.

Cancer Advocates Applauds the House’s Passage of Biomarker Testing Legislation, Ensuring Ohioans Have Better Access to Personalized Care.

Earlier today, the Pennsylvania State Senate unanimously passed House Bill 1754, the bipartisan proposal to increase access to biomarker testing. The bill will now go to Governor Shapiro’s desk, providing him the opportunity to ensure coverage of this essential testing for more Pennsylvanians. The American Cancer Society Cancer Action Network (ACS CAN) and the PA Biomarker Testing Coalition are advocating for this significant policy change to ensure more cancer patients and people with other illnesses and diseases can get the testing needed to access precision medicine.

Today, the Food and Drug Administration (FDA) dealt a blow to public health by authorizing the sale of four menthol e-cigarettes manufactured by NJOY LLC.